<DOC>
	<DOC>NCT01843023</DOC>
	<brief_summary>The purpose of this study is to compare 6-month treatment outcomes for 15-21 year old opioid-dependent youth receiving extended release naltrexone (XR-NTX) v. Treatment as Usual (TAU).</brief_summary>
	<brief_title>Extended Release Naltrexone for Opioid-Dependent Youth</brief_title>
	<detailed_description>This proposed study is a 6-month, two-group randomized clinical trial of XR-NTX v. TAU for 340 opioid-dependent youth ages 15-21. The study will be conducted at Mountain Manor Treatment Center, a community drug treatment program in Baltimore. TAU will consist of buprenorphine treatment of opioid withdrawal followed by counseling with or without continued buprenorphine.</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Analgesics, Opioid</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Meets Diagnostic and Statistical ManualIV criteria for opioid dependence, physiologic subtype; Within 3 days of admission to MMTC; Age between 15 and 21, inclusive; Able and willing to provide informed consent to be randomly assigned to XR NTX or TAU; and for participants under 18 years of age, parental or guardian consent and participant assent. Liver function test levels (Alanine Transaminase, Aspartate Transaminase) four times greater than normal; Unstable medical or psychiatric illness (e.g., schizophrenia) that might make participation hazardous; History of serious suicide attempt in the past 6 months; History of allergic reaction to naloxone, and/or naltrexone; Current chronic pain condition for which opioids are deemed necessary for ongoing care; blood coagulation disorder (e.g., hemophilia); Body Mass Index &gt; 40; If female, pregnant, lactating, unwilling or unable (due to parental objection) to use FDAapproved contraceptive methods; meeting DSMIV criteria for benzodiazepine dependence</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>opioid dependence</keyword>
</DOC>